Adjuvant Topical Tranexamic Acid in Decompressive Spinal Metastasis Surgery

Spine (Phila Pa 1976). 2022 01-Feb;():. 10.1097/BRS.0000000000004280

Denosumab noninferior to zoledronic acid in the treatment of bone metastasis

J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22

Reduction in Odds of Pathological Fracture with Denosumab vs Zoledronic Acid for Bone Metastases

J Am Acad Orthop Surg Glob Res Rev. 2020 Aug-01;():. 10.5435/JAAOSGlobal-D-20-00045

Oral ibandronic acid inferior to IV zoledronic acid for metastatic breast cancer to bone

Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4.

Zoledronate reduces radiation-induced bone collagen degradation in radiation therapy

Clin Transl Oncol. 2015 Jun;17(6):454-61.

Preoperative embolization does not reduce blood loss in spinal metastases treatment

J Vasc Interv Radiol. 2015 Mar;26(3):402-412.e1.

Early vs standard zoledronic acid treatments for prostate cancer metastatic to bone

J Clin Oncol. 2014 Apr 10;32(11):1143-50. doi: 10.1200/JCO.2013.51.6500.

COA 2020: No Improvement in Survival Trend for Surgically Treated Appendicular Bone Metastases

Electro-acupuncture reduces arthralgia in cancer patients taking aromatase inhibitors

Eur J Cancer. 2014 Jan;50(2):267-76. doi: 10.1016/j.ejca.2013.09.022. Epub 2013 Oct 24

Ewing sarcoma: Similar survival rates with intensified dose regimen of VDC/IE

J Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6

Muramyl tripeptide in chemotherapy improves overall osteosarcoma survival

J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095

Significant blood loss during spinal tumour surgery &surgery for metastatic spinal disease

Bone Joint J. 2013 May;95-B(5):683-8. doi: 10.1302/0301-620X.95B5.31270

MTP-PE added to chemotherapy did not improve outcomes in metastatic osteosarcoma patients

Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566

Balloon kyphoplasty more effective than non-surgical treatment in cancer patients with VCF

Lancet Oncol. 2011 Mar;12(3):225-35. doi: 10.1016/S1470-2045(11)70008-0. Epub 2011 Feb 16